Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Boca Raton, FL
SEC filing record 1 source field available
Fiscal year end
31 December
TherapeuticsMD, Inc. has filed 1,173 SEC EDGAR filings since 16 Aug 1995

SEC filing history

Showing 626-650 of 960 matching filings.

Per page
25
Current page
26
4

OWNERSHIP DOCUMENT

Filing date
21 Dec 2015
Reporting date
17 Dec 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
21 Dec 2015
Reporting date
17 Dec 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
21 Dec 2015
Reporting date
17 Dec 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
21 Dec 2015
Reporting date
17 Dec 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
21 Dec 2015
Reporting date
17 Dec 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
21 Dec 2015
Reporting date
17 Dec 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
21 Dec 2015
Reporting date
17 Dec 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
21 Dec 2015
Reporting date
17 Dec 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
21 Dec 2015
Reporting date
17 Dec 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
21 Dec 2015
Reporting date
17 Dec 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-00100

8-K filing

Filing date
07 Dec 2015
Reporting date
07 Dec 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-207837

EFFECT filing

Filing date
17 Nov 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-00100

CURRENT REPORT

Filing date
17 Nov 2015
Reporting date
17 Nov 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
13 Nov 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
13 Nov 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3 File 333-207837

S-3

Filing date
05 Nov 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-00100

QUARTERLY REPORT

Filing date
05 Nov 2015
Reporting date
30 Sep 2015
Next action
Verify source filing
8-K File 001-00100

CURRENT REPORT

Filing date
04 Nov 2015
Reporting date
04 Nov 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-00100

CURRENT REPORT

Filing date
13 Oct 2015
Reporting date
13 Oct 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
27 Aug 2015
Reporting date
25 Aug 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
24 Aug 2015
Reporting date
20 Aug 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-00100

CURRENT REPORT

Filing date
17 Aug 2015
Reporting date
17 Aug 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-00100

QUARTERLY REPORT

Filing date
07 Aug 2015
Reporting date
30 Jun 2015
Next action
Verify source filing
8-K File 001-00100

CURRENT REPORT

Filing date
06 Aug 2015
Reporting date
06 Aug 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-00100

FORM 8-K

Filing date
15 Jul 2015
Reporting date
09 Jul 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .